文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于患者年龄的乳腺导管原位癌病理特征差异。

Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.

作者信息

Goldstein N S, Vicini F A, Kestin L L, Thomas M

机构信息

Department of Anatomic Pathology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA.

出版信息

Cancer. 2000 Jun 1;88(11):2553-60. doi: 10.1002/1097-0142(20000601)88:11<2553::aid-cncr18>3.0.co;2-v.


DOI:10.1002/1097-0142(20000601)88:11<2553::aid-cncr18>3.0.co;2-v
PMID:10861433
Abstract

BACKGROUND: Young patient age at diagnosis has been reported as a risk factor for recurrence in patients with ductal carcinoma in situ (DCIS) of the breast treated with breast-conserving therapy (BCT). The authors examined pathologic features of DCIS in three different age groups of patients to identify differences that might explain why young patient age at the time of diagnosis is a risk factor for recurrence. METHODS: Excised specimens from 177 breasts of 172 patients with DCIS treated with BCT were studied. All slides from all specimens were reviewed. Patients were divided into 3 age groups: those age < 45 years, those ages 45-59 years, and those age >/= 60 years. The histologic features that were quantified included most common and highest nuclear grades, DCIS architectural pattern, amount of central necrosis (quartiles), calcifications, amount of DCIS, and number of terminal duct lobular units (TDLUs) with cancerization of lobules (COL) within 0.42 cm of the margin, margin status, and size and volume of excision specimens. RESULTS: Patients age < 45 years at the time of diagnosis more frequently had higher nuclear grade DCIS (highest nuclear Grade 3: 69%, 60%, and 39%; P = 0.003), respectively and central necrosis (72%, 62%, and 44%; P = 0. 01), respectively. Although not statistically significant, younger patients tended to have comedo subtype DCIS more often (31%, 23%, and 19%; P = 0.35), respectively. Younger patients also more often had smaller initial biopsy specimen maximum dimensions (4.3 cm, 5.2 cm, and 5.7 cm; P = 0.004), respectively, with close or positive margins (89%, 61%, and 64%; P = 0.03), and more TDLUs with COL in the 0.42-cm rim of tissue adjacent to the margin (5.2, 3.6, and 1.9; P = 0.23), respectively. No other features including the amount of DCIS when classified as > 50% or > 75% of ducts, calcifications within DCIS ducts, pattern of DCIS involvement, number of slides examined, number of slides with DCIS, and mean number of DCIS ducts near the margin were found to occur more frequently in younger patients. CONCLUSIONS: Younger patients with DCIS may have an increased risk of local recurrence when treated with BCT due to smaller initial excision volumes, a greater proportion of high nuclear grade DCIS, and central necrosis.

摘要

背景:据报道,对于接受保乳治疗(BCT)的乳腺导管原位癌(DCIS)患者,诊断时年龄较轻是复发的一个危险因素。作者研究了三个不同年龄组DCIS患者的病理特征,以确定可能解释为何诊断时年龄较轻是复发危险因素的差异。 方法:对172例接受BCT治疗的DCIS患者的177个乳房切除标本进行研究。对所有标本的所有切片进行复查。患者分为3个年龄组:年龄<45岁、年龄45 - 59岁、年龄≥60岁。定量的组织学特征包括最常见和最高核分级、DCIS的结构模式、中央坏死量(四分位数)、钙化、DCIS量、以及距切缘0.42 cm内有小叶癌变(COL)的终末导管小叶单位(TDLU)数量、切缘状态、切除标本的大小和体积。 结果:诊断时年龄<45岁的患者更常出现核分级较高的DCIS(最高核分级3级:分别为69%、60%和39%;P = 0.003),以及中央坏死(分别为72%、62%和44%;P = 0.01)。虽然无统计学意义,但年轻患者更倾向于出现粉刺型DCIS(分别为31%、23%和19%;P = 0.35)。年轻患者初始活检标本的最大尺寸也更小(分别为4.3 cm、5.2 cm和5.7 cm;P = 0.004),切缘接近或阳性者更多(分别为89%、61%和64%;P = 0.03),且在距切缘0.42 cm的组织边缘内有COL的TDLU更多(分别为5.2、3.6和1.9;P = 0.23)。未发现其他特征在年轻患者中更频繁出现,包括DCIS量分类为>50%或 >75%导管时、DCIS导管内的钙化、DCIS累及模式、检查的切片数量、有DCIS的切片数量以及切缘附近DCIS导管的平均数量。 结论:接受BCT治疗的年轻DCIS患者可能因初始切除体积较小、高核分级DCIS比例较高以及中央坏死而局部复发风险增加。

相似文献

[1]
Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.

Cancer. 2000-6-1

[2]
Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.

Am J Surg Pathol. 2000-8

[3]
Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy.

Am J Surg Pathol. 1999-11

[4]
Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.

Breast J. 2005

[5]
Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.

Cancer. 2000-2-1

[6]
The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.

Cancer. 2002-4-1

[7]
Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.

Am J Surg Pathol. 2009-12

[8]
Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.

Ann Surg Oncol. 2009-7-28

[9]
Evaluating the relationship between ductal carcinoma in situ, calcifications, and margin status in patients undergoing breast conserving surgery.

J Surg Oncol. 2019-5

[10]
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

J Clin Oncol. 2001-4-15

引用本文的文献

[1]
MRI-detected tumor deposits in cT3 and cT4 rectal cancer following neoadjuvant chemoradiotherapy.

Eur Radiol. 2024-5

[2]
Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.

Ann Surg Oncol. 2022-12

[3]
Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013).

Clin Transl Oncol. 2018-12-10

[4]
Retrospective analysis of breast cancer prognosis among young and older women in a Brazilian cohort of 738 patients, 1985-2002.

Oncol Lett. 2016-12

[5]
Current view on ductal carcinoma in situ and importance of the margin thresholds: A review.

Facts Views Vis Obgyn. 2014

[6]
Predicting invasive breast cancer versus DCIS in different age groups.

BMC Cancer. 2014-8-11

[7]
Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study.

Pathol Oncol Res. 2014-7

[8]
Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review).

Int J Oncol. 2012-6-20

[9]
Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS).

PLoS One. 2010-8-10

[10]
Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.

Am J Surg Pathol. 2009-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索